Navigation Links
B. Braun Renal Therapies Division Announces Availability of Adimea

BETHLEHEM, Pa., April 27 /PRNewswire/ -- The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) has announced the U.S. introduction of Adimea™, an innovative process for real-time monitoring of dialysis effectiveness during treatment.

(Logo: )

Adimea, developed by B. Braun and already in use in Europe, is designed for use with B. Braun's Dialog+ Hemodialysis System, provides healthcare professionals with the information they need to give patients the optimal dialysis dose (Kt/V).

U.S. FDA-cleared, the Adimea process uses spectroscopy principles to measure dialysis efficiency by determining the reduction in the molar concentration of urinary excreted substances in the spent dialysate by transmitting an ultraviolet (UV) light source through the dialysate. The highly reliable and precise instrument allows the online determination and continual monitoring of current Kt/V values throughout the patient's entire treatment.  

"Adimea is a very important advancement in renal therapies," said Samuel Amory, Vice President, Renal Therapies Division for B. Braun Medical Inc. "It helps healthcare professionals give their patients an optimal dialysis dose and allows them to adjust treatment parameters for the benefit of patients even during treatment."  

Easy to use and efficient, Adimea requires the entry of only one patient parameter – the patient's weight before dialysis. It saves time by eliminating the determination and entry of the urea volume (V), which enables healthcare professionals to focus more attention on patient care.

For more information or to order Adimea, call 800-848-2066.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at or visit B. Braun at

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
2. B. Braun Awarded Contract With HealthTrust Purchasing Group to Provide Pain Management Solutions
3. B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings
4. MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical Treatment for Cardiovascular Disease
5. B. Braun Introduces WHIN(R) Safe Huber Needle
6. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
7. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
10. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
11. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
Post Your Comments:
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the German ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
Breaking Medicine Technology:
(Date:11/29/2015)... Viejo, CA (PRWEB) , ... November 29, 2015 ... ... an all new and unique analog distortion effect tool designed specially for Final ... their footage, and create limiltess looks with the easy-to-use modification controls. Destoying and ...
(Date:11/29/2015)... Jose, CA (PRWEB) , ... November 29, 2015 , ... ... Area, is proud to announce their December, 2015, featured apartment community: Epic. In showcasing ... for corporate housing in the tight Bay Area rental market to efficiently find housing ...
(Date:11/28/2015)... ... ... Safe storage for contraceptive devices may not always be easy to find. However, ... other from Bradley Beach, New Jersey, there is an easy solution to the problem. ... NuvaRings more often than necessary. As such, it affords peace of mind and eliminates ...
(Date:11/28/2015)... ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 ... savings. , With possible savings of up to 20% off orders $80 or more to ... the website every few hours. , As a competitive e-commerce website for skin care and ...
(Date:11/27/2015)... Toronto, Canada (PRWEB) , ... November 28, 2015 , ... ... How do we outperform our billings from last year? , This question has not ... many organizations are coming to the retirement age and the younger workforce don’t share ...
Breaking Medicine News(10 mins):